Trinity Innovation Bioventure Singapore
Venture capitalSingapore · Seed–Late Stage · 3 people tracked
Investment thesis
The firm is a licensed biomed venture capital fund pursuing innovation and value investment, drawing on deep insight and experience in Asian markets. It is part of the Trinity Innovation Fund group, founded in 2018, which manages multiple VC funds across the region. The team is led by industry veterans who have run several VC funds and invested in dozens of biotech companies.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from public directories
What they invest in
from 1 of 5 portfolio companiesAI & Machine Learning ×1Biotech ×1Healthtech ×1
Investments · 5 tracked
founders shown can be your intro pathCo-investorsAvoro Capital AdvisorsVivo Capital
Biotech company that raised US$32M in Series A funding.
HiFiBiO Therapeutics develops immunotherapies for patients with high unmet medical needs, using its Drug Intelligence Science (DIS) platform that combines single cell technology with AI/ML analytics.
AI & Machine LearningBiotechHealthtech
Liang Schweizer(Founder)in
Co-investorsB Capital GroupB4 Capital
Developer of RNAi therapeutics for metabolic and liver diseases, partnered with Boehringer Ingelheim
Biopharmaceutical company that raised US$42M in Series A+ financing.
Frequently asked questions
- How many investments has Trinity Innovation Bioventure Singapore made?
- Trinity Innovation Bioventure Singapore has 5 tracked investments.
- What stage does Trinity Innovation Bioventure Singapore invest at?
- Trinity Innovation Bioventure Singapore invests at the Seed, Series A, Growth, Late Stage stages.
- What sectors does Trinity Innovation Bioventure Singapore focus on?
- Trinity Innovation Bioventure Singapore focuses on Biotech, Digital Health, Medical Devices, Sector Agnostic.
- Where is Trinity Innovation Bioventure Singapore located?
- Trinity Innovation Bioventure Singapore is headquartered in Singapore, SG.
- Does Trinity Innovation Bioventure Singapore lead rounds?
- Trinity Innovation Bioventure Singapore typically participates in rounds rather than leading them.
- Who does Trinity Innovation Bioventure Singapore co-invest with?
- Trinity Innovation Bioventure Singapore most often shares deals with Avoro Capital Advisors, B Capital Group, B4 Capital, among 4 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.